LODAAT Pharma is a prominent American firm specialising in the pharmaceutical industry, providing a diverse portfolio of innovative high-value molecules, including Biosimilars, Biologics, Rare Disease, and Orphan Drugs. The company is also highly regarded for its consumer health group, which excels in the development of over-the-counter (OTC) products across key therapeutic categories such as pain management, inflammation, and gut microbiome health. In addition to these sectors, LODAAT Pharma stands out as a leading investor in new chemical entities (NCEs) and new drug development in oncology, cognition, cardiovascular, and other therapeutic areas. The firm is committed to forging partnerships with global leaders who share a vision for advancing cutting-edge therapeutics.

Services include:
- Contract Development and Manufacturing (CDMO)
- Finished Dosage Forms

As a supplier to the pharmaceutical industry, LODAAT Pharma is dedicated to innovation and excellence in its services, creating valuable partnerships while focusing on the development of advanced therapeutics. For further information, please visit lodaatpharma.com.